Current pharmacotheraupeutical options of lower urinary tract symptoms
Authors:
Marcela Fontana
Authors‘ workplace:
Urologická klinika 2. LF UK, Praha
Published in:
Čes. slov. Farm., 2025; 74, 90-93
Category:
Current Pharmacotherapy
doi:
https://doi.org/10.36290/csf.2025.012
Overview
Lower urinary tract symptoms (LUTS) represent a wide unit with multifactorial etiology, and therefore, treatment is not uniform. In most patients with LUTS, pharmacotherapy is an effective option for managing these symptoms, thereby improving the quality of life. We have medications from various drug classes available, which can be effectively combined to achieve the best therapeutic outcome. The following text provides an overview of the current pharmacotherapy for LUTS.nce-based medicine principles are essential when searching for and critically evaluating information use in pregnancy.
Keywords:
pharmacotherapy – LUTS – phosphodiesterase 5 inhibitors – lower urinary tract symtoms – α-1 adrenoreceptor antagonists – 5α-reductase inhibitors – muscarinic receptor antagonists – beta-3 agonists
Labels
Pharmacy Clinical pharmacologyArticle was published in
Czech and Slovak Pharmacy
2025 Issue 2
Most read in this issue
- Good storage practices for medical devices and in vitro diagnostic medical devices by healthcare providers
- Proposal of limit values for surface contamination by cytotoxic drugs in pharmacies and hospitals
- Photoprotection
- Current trends in insulin therapy